Search tips
Search criteria 


Logo of arsMary Ann Liebert, Inc.Mary Ann Liebert, Inc.JournalsSearchAlerts
Antioxidants & Redox Signaling
Antioxid Redox Signal. 2011 September 1; 15(5): 1405–1414.
PMCID: PMC3144425

Flow Shear Stress and Atherosclerosis: A Matter of Site Specificity


It is well accepted that atherosclerosis occurs in a site-specific manner especially at branch points where disturbed blood flow (d-flow) predisposes to the development of plaques. Investigations both in vivo and in vitro have shown that d-flow is pro-atherogenic by promoting oxidative and inflammatory states in the artery wall. In contrast, steady laminar blood flow (s-flow) is atheroprotective by inhibition of oxidative stress and inflammation in the vessel wall. The mechanism for inflammation in endothelial cells (ECs) exposed to d-flow has been well studied and includes redox-dependent activation of apoptosis signal-regulating kinase 1 (ASK1) and Jun NH2-terminal kinase (JNK) that ultimately lead to the expression of adhesive molecules. In contrast, s-flow leads to the activation of the mitogen extracellular-signal-regulated kinase kinase 5/extracellular signal-regulated kinase-5 (MEK5/ERK5) pathway that prevents pro-inflammatory signaling. Important transcriptional events that reflect the pro-oxidant and pro-inflammatory condition of ECs in d-flow include the activation of activator protein 1 (AP-1) and nuclear factor kappaB (NFκB), whereas in s-flow, activation of Krüppel-like factor 2 (KLF2) and nuclear factor erythroid 2-like 2 (Nrf2) are dominant. Recent studies have shown that protein kinase c zeta (PKCζ) is highly activated under d-flow conditions and may represent a molecular switch for EC signaling and gene expression. The targeted modulation of proteins activated in a site-specific manner holds the promise for a new approach to limit atherosclerosis. Antioxid. Redox Signal. 15, 1405–1414.


In the late 15th century, Leonardo Da Vinci documented the potential importance of hemodynamics for cardiovascular tissue. Da Vinci wrote that he expected blood flow in the heart to be subjected to similar principles as those he had observed in the flow of water around obstacles in nature. In the 19th century, the great pathologists Rokitansky (78) and Virchow (90) recognized that the distribution of atherosclerotic lesions was nonuniform and postulated that mechanical forces operating in different regions of the arterial tree may be responsible. Fry (31) and Caro and coworkers (8, 10) investigated the fluid dynamics of lesion-susceptible sites of large arteries and established several important concepts with respect to the role of hemodynamics in atherogenesis. Classic investigations of the hemodynamic role in lesion distribution have been carried out by Glagov, Zarins, Giddens, and coworkers (47, 48, 98). The molecular mechanisms linking endothelial flow responses to the pathogenesis of atherosclerosis are complex and difficult to dissect (38). However, recent publications have presented new steps toward the understanding of how the cell senses shear stress, and what signaling pathways and genes are regulated. The main objectives of this review are (i) to document the current state of knowledge concerning endothelial response to mechanical forces related to blood flow, (ii) to present specific differences in both signaling mechanisms and gene expression that occur under steady laminar blood flow (s-flow) and/or disturbed blood flow (d-flow) patterns, and (iii) to suggest new candidates and future directions into endothelial mechanotransduction to prevent atherogenesis.

Flow Confers an Atheroprotective Force

Blood vessels are constantly exposed to various types of hemodynamic forces (including fluid shear stress, cyclic stretch, and hydrostatic pressure) induced by the pulsatile blood flow and pressure (Fig. 1). Shear stress is the force per unit area created when a tangential force (blood flow) acts on a surface (endothelium) (22). The magnitudes of shear stress range from 0.1 N/m2 (1 dyn/cm2) to 0.6 N/m2 (6 dyn/cm2) in the venous system and from 1 N/m2 (10 dyn/cm2) to 7 N/m2 (70 dyn/cm2) in the arterial vessels (56, 63).

FIG. 1.
Hemodynamic forces on the vessel wall. A section of the artery wall showing that blood flow generates three major mechanical forces: shear stress (parallel to the vessel wall), hydrostatic pressure (perpendicular to the vessel wall), and cyclic stretch ...

There is a considerable amount of evidence that hemodynamic characteristics determine the location of lesions and contribute to the pathogenesis of atherosclerosis (56, 93). In fact, atherosclerotic lesions are preferentially located at the outer walls of the arterial branches and curvatures, where the local flow is disturbed (e.g., nonuniform, irregular oscillation, and recirculation) (3, 9, 48, 98).

S-flow and sustained high shear stress, as seen in the straight part of the arterial tree, modulate the expression of genes and proteins in endothelial cells (ECs) to protect against atherosclerosis. d-flow and reciprocating shear stress with little forward direction, as seen in vascular branch points and other regions of complex flow, cause the expression of atherogenic genes and proteins that predispose these areas to atherosclerosis.

Direct measurements and fluid mechanical analyses of models of these lesion-prone areas have revealed that shear stress is on the order of ± 0.4 N/m2 (4 dyn/cm2) in d-flow areas and >1.2 N/m2 (12 dyn/cm2) in the s-flow areas (56). Thus, s-flow plays protective roles against atherosclerosis, whereas d-flow may act as detrimental mechanical stimuli contributing to atherogenesis (33, 56, 63, 93) (Fig. 2).

FIG. 2.
Vascular bifurcation and flow patterns at an area of atherosclerotic plaque. Straight regions of arteries are exposed to s-flow and are protected from atherosclerosis. Regions of bifurcations are characterized by d-flow that predisposes to atherosclerosis. ...

Effect of Flow Shear Stress on EC Phenotype

ECs are in direct contact with the flowing blood and therefore bear most of the wall shear stress. Evidence of direct effects of shear stress on endothelial structure and function has been obtained primarily from in vitro studies using cultured ECs exposed to different types of flow shear stress (e.g., laminar, pulsatile, disturbed, or reciprocating flow). These studies have suggested that ECs not only sense and respond to shear stress, but also react specifically to different types of shear stress (5, 37, 74). Importantly, continually sheared ECs exhibit a new phenotype. In particular, sustained s-flow determines a cell cycle arrest in the G0 or G1 phase (52). In contrast, EC turnover is accelerated in d-flow (17). This effect may be related to the release of p21 suppression of cyclin-dependent kinase activity via G0/G1-S transition (2, 23). Such accelerated cell turnover may explain the enhanced macromolecular permeability and increased lipid uptake in the d-flow areas of the vascular tree, resulting in a particular propensity to develop atherosclerosis (15). In addition to the new phenotype changes, continually sheared ECs exhibit a different morphology (12, 57, 91, 92). In response to sufficient magnitude and duration of s-flow, ECs become aligned and elongated in the direction of the flow, with a significant alteration in cytoskeletal architecture. In contrast, in response to d-flow, cells appear with a more polygonal appearance without a clear orientation. This observation on EC morphological responses induced by different pattern of flow in vitro recapitulates many of the morphological features that have been described in vivo (50).

These profound morphological adaptations to shear stress are driven by a novel reorganization of actin in stress fibers (67), redistribution of focal adhesion complexes (34, 67), and partial disassembly and reassembly of cell–cell junctional complexes (66). A recent article shows that Krüppel-like factor 2 (KLF2) is essential for shear stress-induced cell alignment, concomitant shear fiber assembly, and inhibition of Jun NH2-terminal kinase (JNK) and its downstream targets ATF2/c-Jun (7).

Imposition of shear stress on cultured endothelium also induces planar cell polarity (PCP) in the downstream direction (89). PCP occurs when cell organelles, cytoskeleton, and/or adhesion complexes exhibit unidirectional organization along an axis that lies in the plane of a cell monolayer. McCue et al. showed a novel mode of mechanosensitive PCP that is tightly regulated by glycogen synthase kinase 3 beta (GSK-3β), proving that manipulation of GSK-3β could induce polarity of these cells to reverse direction (58). This is a capacity not displayed by any other cell type studied to date. Remarkably, ECs display PCP in vitro and in intact blood vessels (77). However, the origins of this polarity are controversial because microtubule polarity in vivo varies among blood vessels (76, 77). Specifically, PCP is often directed upstream in arteries and downstream in veins, a finding that has led to the inference that it is independent of shear stress.

Polarity of many cell types is controlled by the partitioning-defective (PAR) complex consisting of PAR-3, PAR-6, and protein kinase c zeta (PKCζ). This ternary complex is part of an evolutionary conserved molecular cassette with fundamental roles in cell polarity in a variety of biological context (6, 45, 46, 80).

We have recently reported that PKCζ is highly modulated by shear stress patterns and is able to decrease the shear stress-induced KLF2 promoter activity (65).

Difference in Signaling Mechanism in s-Flow Compared to d-Flow Patterns

As shear stress acts at the surface of luminal cells, local membrane structure can participate in mechanotransduction. Several mechanosensing candidates have been proposed although it is not clear how they orchestrate responses to shear stress. Examples include activation of ion channels, G proteins, glycocalix, and primary cilia, and changes in phospholipid metabolism and membrane fluidity (22). In vitro studies using parallel-plate flow chamber or cone-and-plate viscometer (75) have shown that the activation of mechanosensors by shear stress leads to the activation of specific signaling pathways, with Ras serving as an upstream molecule and with three key downstream mitogen-activated protein kinases (MAPKs) molecules: extracellular signal-regulated kinase (ERK), JNK, and p38.

A crucial s-flow-mediated atheroprotective mechanism is the mitogen extracellular-signal-regulated kinase kinase 5 (MEK5)-ERK5-KLF2 pathway. ERK5 is critical to EC functions as shown by the fact that ERK5 knockout mice have impaired vascular development (73) and the inhibition of ERK5 promotes EC apoptosis (71). We have shown that s-flow potently activates ERK5 (86) and inhibits leukocyte binding as well as adhesion molecule expression (18). We have also reported that s-flow-induced peroxisome proliferator-activated receptor γ1 (PPARγ1) activation via ERK5 contributes to the anti-inflammatory and atheroprotective effects of s-flow. In addition, we and others have demonstrated that s-flow-mediated ERK5 activation induces KLF2, a recently identified transcriptional activator of endothelial nitric oxide synthase (eNOS) and inhibitor of EC inflammation (1, 69).

Moreover, using both in vitro cultured ECs (54, 86) and ex vivo intact vessels (96), we have demonstrated that inhibition of tumor necrosis factor-alpha (TNFα)-mediated activation of the Apoptosis signal-regulating kinase 1 (ASK1) pathway is one mechanism by which s-flow is atheroprotective. ASK1 has been shown to play a key role in vascular dysfunction. Yamashita et al. (94) reported that ASK1 contributes to endothelial dysfunction by reducing eNOS activity and activating reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. ASK1 is a 170-kDa protein that functionally is composed of an inhibitory N-terminal domain, an internal kinase domain, and a C-terminal regulatory domain. The C-terminal domain of ASK1 binds to TNF receptor-associated factor 2 (TRAF2) and this association is required for ASK1 activation by cytokines. The C-terminal domain contains Ser967, which when phosphorylated creates a motif for 14-3-3 binding that inhibits ASK1. We recently showed that 14-3-3 is an important regulator in s-flow-mediated inhibition of TNFα-stimulated ASK1-mediated JNK activation (54). It has also been shown that thioredoxin-1 (Trx1), in a reduced form, binds to the N-terminal part of ASK1 and blocks activation of ASK1 by TNFα (35, 53, 79). Apoptotic stimuli (TNFα or reactive oxygen species [ROS]) activate ASK1 in part by oxidizing Trx1 to release Trx1 from ASK1 (35, 53, 79). Our recently published data (95, 96) suggest that s-flow increases Trx1 activity, thereby inhibiting ASK1-JNK activation. These data suggest that s-flow modulates the EC redox state, subsequently regulating Trx1 binding to ASK1. This may be an important mechanism to explain the observations that s-flow prevented EC apoptosis induced by TNFα (27).

Difference in Gene Expression in s-Flow Compared to d-Flow Patterns

The activation of the pathways described above leads to the regulation of pathophysiologically relevant genes, whose expression is modulated by different types of shear stress.

Several studies have been performed to identify the differences, on the transcriptomic level, of ECs exposed to shear stress compared to control conditions. One of the first studies described that ECs in s-flow (atheroprotected) regions of pig aortas have lower expressions of both pro- and anti-inflammatory genes (70). Using a similar full-genome approach, Dekker et al. (25) identified KLF2 as a transcription factor specifically induced by s-flow in ECs. Further, KLF2 was found not to be induced by other stimuli that govern the endothelial transcriptome. Nuclear factor erythroid 2-like 2 (Nrf2) was also identified as a shear-induced transcription factor that is responsible for antioxidant gene expression (14). It has also been shown that both of these transcription factors are induced in s-flow regions of the vasculature in vivo as well (20, 26).

In addition, it was shown that KLF2 improves the nuclear localization of Nrf2 and the combined actions of these two factors constitute about 70% of the s-flow-induced endothelial gene expression (29). Nrf2 potently induces anti-inflammatory/antioxidant enzymes, whereas KLF2 induces anti-inflammatory and anticoagulant proteins, most specifically eNOS and thrombomodulin. KLF2 also inhibits proinflammatory and antifibrinolytic genes through inhibition of the proinflammatory transcription factors nuclear factor kappaB (NFκB) and activator protein (AP-1).

On the other hand, d-flow activates NFκB and AP-1 in ECs. Nagel et al. (62) demonstrated that ECs subjected to d-flow exhibit increased levels of localized NFκB, c-Jun, and c-fos in their nuclei, as compared with the cells exposed to s-flow or maintained under static conditions. The activation of these transcription factors leads to the upregulation of pro-inflammatory and pro-atherogenic genes such us intercellular adhesion molecule 1 (ICAM-1), E-selectin, platelet-derived growth factor (PDGF)-BB, interleukin (IL)-1α (21, 97), bone morphogenic protein-4 (BMP-4) (84), monocyte chemotactic protein-1 (MCP-1) (39), and the vasoconstrictor endothelin-1 (ET-1) (99). Based on these data, s-flow activates KLF2 and Nrf2, which inhibit inflammation, whereas d-flow activates NFκB and AP-1, which promote inflammation (Fig. 3).

FIG. 3.
Signaling pathways activated by s-flow and d-flow. s-flow activates the MEK5/ERK5/KLF2 cascade and also determines the translocation of Nrf2 to the nucleus after Keap1 is dissociated and degradated. KLF2 and Nrf2 mediate the anti-inflammatory effects ...

More recently Jo's group reported flow-sensitive gene changes using the mouse model of d-flow (64), discovering numerous novel mechanosensitive molecules and providing additional support for the flow-dependent regulation of KLF2.

Conklin et al. (19) also demonstrated that d-flow increases vascular endothelial growth factor (VEGF) expression. These changes in VEGF expression may suggest a possible molecular mechanism for increased endothelial permeability in regions of d-flow. Other findings demonstrate that d-flow increases the interaction between the white blood cells in the flowing blood and ECs, contributing to the regional propensity for inflammatory cell recruitment in areas prone to atherosclerosis (13, 16).

All together, these results suggest that different patterns of shear stress selectively regulate gene expression tipping the balance toward anti-inflammatory and antiatherogenic effect in s-flow conditions versus pro-inflammatory and pro-atherogenic status in d-flow settings.

Different Patterns of Flow Shear Stress and ROS

ROS acts as mediators in EC responses to shear stress. The basic product of enzymatic ROS production is the superoxide anion (O2•−), which is converted quickly into hydrogen peroxide (H2O2) by superoxide dismutase (SOD). The H2O2 is transformed in its turn by two enzymes, catalase and glutathione peroxidase (GPx). The most relevant sources of ROS, with respect to vascular disease, appear to be NADPH oxidase, xanthine oxidase (XO), uncoupled eNOS, cytochrome P450, and the mitochondrial respiratory chain (51, 85). Conversely, ROS production is kept in check by antioxidant defenses such as SOD, catalase, and GPx, but also Trx1 and heme oxygenase (HO-1).

Laurindo et al. (49) observed ROS generation after flow changes in vitro and in vivo using electron paramagnetic resonance spectroscopy. Since then, it has been well established that shear stress causes the generation of not only NO, but also ROS in isolated ECs as well as in intact vessels and tissue. In particular, continuous oscillatory shear in human umbilical vein endothelial cells (HUVECs) results in oxidative stress by increasing of intracellular O2•−. The increased O2•− production is dependent on reduced nicotinamide adenine dinucleotide (NADH) oxidase activity, and HO-1 mRNA (24). Further, O2•− production is increased by the upregulation of subunits of the NADPH oxidase complex, such as p47phox (42), p22phox (81), gp91phox, and NOX4 expression (41) (Fig. 4). O2•− generation by oscillating shear is also reliant upon the balance of XO and dehydrogenase in ECs (59, 60). Under this condition of oxidative stress, the activity of both O2•− and NO-generating enzymes results in protein nitrosylation through ONOO formation, as found in areas at risk of atherosclerosis (40). This modulation of gene expression and increased ROS production correlates well with low-density lipoprotein oxidation, MCP-1 expression, and monocyte-EC binding (42).

FIG. 4.
Balance between antioxidant and pro-oxidant enzymes under s-flow and d-flow conditions. S-flow induces the expression of antioxidant enzymes that tip the balance toward a reducing environment, whereas d-flow upregulates pro-oxidant enzymes that contribute ...

Moreover, abnormally high flow was recently shown to upregulate NADPH oxidase-dependent ROS production chronically in carotid arteries (11), suggesting that supra-physiological levels of shear stress have a protracted influence on the oxidative status.

Interestingly, onset of s-flow also appears to induce ROS (4, 24). However, in the course of several hours, the effects of flow onset are compensated by antioxidant defenses, such as increased Cu/Zn SOD expression (24, 43) and Mn/SOD (88), upregulation and activation of eNOS, and the subsequent downregulation, by NO, of NADPH oxidase subunits (28), as well as the increased expression of GPx (87), Prx1 (61), and Trx1 (36) (Fig. 4). We have recently shown that s-flow increases G6PD activity (68). G6PD is the rate-limiting enzyme for NADPH formation in ECs and also appears to mediate increases in reduced glutathione (GSH). As a consequence of increased GSH, both Trx1 and glutaredoxin (Grx) are maintained in a reduced form. Reduced Grx and Trx1 bind and inactivate ASK1 decreasing inflammation (vascular cell adhesion molecule 1 [VCAM-1] expression) and atherosclerosis. These data explain how s-flow inhibits inflammation by creating a reducing environment.

Thus, with continuous s-flow applied to cultured cells, ROS are produced, but their bioavailability is reduced over time by ROS-neutralizing enzymes and are overwhelmed by NO availability (Fig. 5). These combined studies explain how s-flow and d-flow produce divergent effects on ROS-producing and ROS-neutralizing enzymes, tipping the balance toward an antioxidative environment in the former condition and oxidative state in the latter (Fig. 4). Hence, ROS generation in ECs exposed to s-flow is a transient response to the change in shear rate, whereas ROS production persists in ECs exposed to d-flow, generating a pro-oxidant and athero-prone condition (Fig. 5).

FIG. 5.
ROS generation in s-flow versus d-flow settings. ROS are generated under s-flow as well as under d-flow conditions. However, s-flow induces only a transient ROS generation because it also increases the expression of antioxidant enzymes that neutralize ...

Site Specificity Mechanisms in d-Flow Areas: Focus on PKCζ

PKCζ is a key mediator of shear stress responses, ROS generation, and inflammation. PKCζ has a conserved carboxyl-terminal catalytic domain and an amino-terminal regulatory domain. The regulatory segment contains a PB1 domain (Phox and Bem1p), which constitutes a recently recognized protein–protein interaction domain found in the atypical protein kinase C (aPKC), and also an autoinhibitory sequence (pseudosubstrate) (Fig. 6). Previous work has shown that TNFα and cycloheximide treatment induces PKCζ (72 kDa) processing into a shorter form, named catalytic domain of PKCζ (CATζ, 50 kDa) (82). This caspase-dependent processing promotes relief of the autoinhibitory state by separating the kinase domain (aa268–335) from the pseudosubstrate autoinhibitory sequence (aa116–122) (83). Caspase 3-dependent processing was also shown to increase PKCζ kinase activity, likely due to loss of endogenous negative regulation (82). We have recently reported that CATζ, generated by caspase-3 cleavage of PKCζ, potentiates a feedback loop that activates JNK to amplify caspase-3 activation and the cleavage of more PKCζ (32). The same pathway was shown both in HUVEC and EC fractions from rabbit aorta (32). Notably, we have found that exposure of ECs to s-flow inhibited JNK-caspase-3-CATζ generation, reducing apoptosis and pro-inflammatory endothelial adhesion protein expression. In addition, PKCζ promotes the adhesive phenotype of ECs when activated by TNFα (72), via stimulation of NFκB-dependent ICAM-1 expression (44, 72). Also, Frey et al. demonstrate a novel function of PKCζ in signaling oxidant generation in ECs by the activation of NADPH oxidase, which may be important in mediating endothelial activation responses (30). Interestingly, Davies group reported that PKCζ is highly modulated by shear stress patterns with increased activity in ECs located in d-flow compared to s-flow regions in pig aortas (55). Because atherosclerotic susceptibility correlates with sites of d-flow we measured PKCζ activation in atherosclerotic regions of mouse aortas. We have found that endothelial PKCζ activation/phosphorylation was elevated in atherosclerotic lesions (d-flow) of the aortic arch compared with nonatherosclerotic (s-flow) regions (Fig. 7) (65). Further, we have demonstrated a critical crosstalk between the pro-inflammatory PKCζ pathway and the anti-inflammatory MEK5/ERK5/KLF2 pathway (Fig. 8) (65). Mechanistically, we have proven that PKCζ binds and phosphorylates ERK5, thereby decreasing eNOS protein stability and contributing to early events of atherosclerosis (65). All these observations suggest that PKCζ activity could be an important determinant of atherogenesis susceptibility via regulation of inflammatory pathways. We will continue to pursue research in our lab with the expectation that it will lead to further evidence in substantiating the role PKCζ has toward the progression of atherosclerosis.

FIG. 6.
PKCζ domains. PKCζ contains a regulatory and a catalytic domain. The regulatory domain is comprised of PB1 and the pseudosubstrate segment. The PB1 domain allows PKCζ to interact with other PB1 domains of scaffolding and anchoring ...
FIG. 7.
PKCζ activation in s-flow and d-flow area of Apoe−/− mice. PKCζ is highly activated/phosphorylated (p-PKCζ, red) in atherosclerotic lesions present in athero-prone regions (lesser curvature, d-flow) compared to ...
FIG. 8.
PKCζ crosstalk between anti-inflammatory and pro-inflammatory pathways. The pro-inflammatory effects of PKCζ are mediated both by inhibiting the MEK5/ERK5/eNOS pathway and by promoting JNK-caspase-3-CATζ generation. These events ...


Studies described in this review highlight current evidence supporting the influence of hemodynamics in the pathogenesis of atherosclerosis.

It is widely recognized that s-flow is atheroprotective, whereas d-flow near arterial bifurcations, branch ostia, and curvatures promotes atherosclerosis. Additionally, vascular endothelium has been shown to sense different flow patterns and to have different, flow-specific behavioral responses both at the molecular and at the cellular levels. Modulation of vascular wall behavior in regions of d-flow in conjunction with the impact of systemic vascular factors such as smoking, hyperlipidemia, hyperglycemia, and hypertension would be an appropriate approach to prevent atherosclerosis and to provide a useful therapeutic intervention. The most common approach to inhibit atherosclerosis has been to activate atheroprotective mechanisms, such as increasing nitric oxide bioavailability. However, we believe that a more elegant approach is to inhibit the atheropromoting mechanisms that occur uniquely in areas of d-flow. Our lab and others have shown that PKCζ-dependent signaling is a unique atheropromoting mechanism that occurs solely in areas of d-flow. Therefore, PKCζ is a prominent example of a regulatory signaling pathway that links extracellular events to intracellular responses, and has been directly implicated in atherogenesis.

Although inconclusive at present, we believe that PKCζ could be an innovative therapeutic target to improve endothelial dysfunction that has been directly implicated in atherogenesis.

Abbreviations Used

activator protein 1
atypical protein kinase C
apoptosis signal-regulating kinase 1
bone morphogenic protein-4
catalytic domain of PKCζ
disturbed blood flow
endothelial cells
endothelial nitric oxide synthase
extracellular signal-regulated kinase-5
glutathione peroxidase
glycogen synthase kinase 3 beta
heme oxygenase
human umbilical vein endothelial cells
intercellular adhesion molecule 1
inhibitor of kappa B
interleukin 1
Jun NH2-terminal kinase
Kelch-like ECH-associated protein 1
Krüppel-like factor 2
mitogen-activated protein kinases
monocyte chemotactic protein-1
mitogen extracellular-signal-regulated kinase kinase 5
nicotinamide adenine dinucleotide
nicotinamide adenine dinucleotide phosphate
nuclear factor kappaB
nuclear factor erythroid 2-like 2
planar cell polarity
platelet-derived growth factor
protein kinase C zeta
peroxisome proliferator-activated receptor gamma 1
reactive oxygen species
steady laminar blood flow
superoxide dismutase
tumor necrosis factor-alpha
TNF receptor-associated factor 2
vascular cell adhesion molecule 1
vascular endothelial growth factor
xanthine oxidase


The authors wish to thank Lindsay A. Marchetti for helping in the figure preparation.


1. Akaike M. Che W. Marmarosh NL. Ohta S. Osawa M. Ding B. Berk BC. Yan C. Abe J. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells. Mol Cell Biol. 2004;24:8691–8704. [PMC free article] [PubMed]
2. Akimoto S. Mitsumata M. Sasaguri T. Yoshida Y. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) Circ Res. 2000;86:185–190. [PubMed]
3. Asakura T. Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990;66:1045–1066. [PubMed]
4. Bao X. Lu C. Frangos JA. Mechanism of temporal gradients in shear-induced ERK1/2 activation and proliferation in endothelial cells. Am J Physiol Heart Circ Physiol. 2001;281:H22–H29. [PubMed]
5. Barakat A. Lieu D. Differential responsiveness of vascular endothelial cells to different types of fluid mechanical shear stress. Cell Biochem Biophys. 2003;38:323–343. [PubMed]
6. Bilder D. Cell polarity: squaring the circle. Curr Biol. 2001;11:R132–R135. [PubMed]
7. Boon RA. Leyen TA. Fontijn RD. Fledderus JO. Baggen JM. Volger OL. van Nieuw Amerongen GP. Horrevoets AJ. KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium. Blood. 2010;115:2533–2542. [PubMed]
8. Caro CG. Fitz-Gerald JM. Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature. 1969;223:1159–1160. [PubMed]
9. Caro CG. Fitz-Gerald JM. Schroter RC. Atheroma and arterial wall shear. Observation, correlation and proposal of a shear dependent mass transfer mechanism for atherogenesis. Proc R Soc Lond B Biol Sci. 1971;177:109–159. [PubMed]
10. Caro CG. Nerem RM. Transport of 14 C-4-cholesterol between serum and wall in the perfused dog common carotid artery. Circ Res. 1973;32:187–205. [PubMed]
11. Castier Y. Brandes RP. Leseche G. Tedgui A. Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res. 2005;97:533–540. [PubMed]
12. Chen BP. Li YS. Zhao Y. Chen KD. Li S. Lao J. Yuan S. Shyy JY. Chien S. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics. 2001;7:55–63. [PubMed]
13. Chen CN. Chang SF. Lee PL. Chang K. Chen LJ. Usami S. Chien S. Chiu JJ. Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow. Blood. 2006;107:1933–1942. [PubMed]
14. Chen XL. Varner SE. Rao AS. Grey JY. Thomas S. Cook CK. Wasserman MA. Medford RM. Jaiswal AK. Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem. 2003;278:703–711. [PubMed]
15. Chien S. Molecular and mechanical bases of focal lipid accumulation in arterial wall. Prog Biophys Mol Biol. 2003;83:131–151. [PubMed]
16. Chiu JJ. Chen CN. Lee PL. Yang CT. Chuang HS. Chien S. Usami S. Analysis of the effect of disturbed flow on monocytic adhesion to endothelial cells. J Biomech. 2003;36:1883–1895. [PubMed]
17. Chiu JJ. Wang DL. Chien S. Skalak R. Usami S. Effects of disturbed flow on endothelial cells. J Biomech Eng. 1998;120:2–8. [PubMed]
18. Collins AR. Meehan WP. Kintscher U. Jackson S. Wakino S. Noh G. Palinski W. Hsueh WA. Law RE. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:365–371. [PubMed]
19. Conklin BS. Zhong DS. Zhao W. Lin PH. Chen C. Shear stress regulates occludin and VEGF expression in porcine arterial endothelial cells. J Surg Res. 2002;102:13–21. [PubMed]
20. Dai G. Vaughn S. Zhang Y. Wang ET. Garcia-Cardena G. Gimbrone MA., Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res. 2007;101:723–733. [PubMed]
21. Dardik A. Chen L. Frattini J. Asada H. Aziz F. Kudo FA. Sumpio BE. Differential effects of orbital and laminar shear stress on endothelial cells. J Vasc Surg. 2005;41:869–880. [PubMed]
22. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6:16–26. [PMC free article] [PubMed]
23. Davies PF. Spatial hemodynamics, the endothelium, and focal atherogenesis: a cell cycle link? [editorial; comment] Circ Res. 2000;86:114–116. [PubMed]
24. De Keulenaer GW. Chappell DC. Ishizaka N. Nerem RM. Alexander RW. Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox-state: Role of a superoxide-producing NADH oxidase. Circ Res. 1998;82:1094–1101. [PubMed]
25. Dekker RJ. van Soest S. Fontijn RD. Salamanca S. de Groot PG. VanBavel E. Pannekoek H. Horrevoets AJ. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2) Blood. 2002;100:1689–1698. [PubMed]
26. Dekker RJ. Van Thienen JR. de Jager SC. Elderkamp YW. Seppen J. de Vries CJ. Biessen EA. van Berkel JC. Pannekoek H. Horrevoets AJ. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol. 2005;167:609–618. [PubMed]
27. Dimmeler S. Haendeler J. Rippmann V. Nehls M. Zeiher AM. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 1996;399:71–74. [PubMed]
28. Duerrschmidt N. Stielow C. Muller G. Pagano PJ. Morawietz H. NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells. J Physiol. 2006;576:557–567. [PubMed]
29. Fledderus JO. Boon RA. Volger OL. Hurttila H. Yla-Herttuala S. Pannekoek H. Levonen AL. Horrevoets AJ. KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28:1339–1346. [PubMed]
30. Frey RS. Rahman A. Kefer JC. Minshall RD. Malik AB. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res. 2002;90:1012–1019. [PubMed]
31. Fry DL. atherogenesis: initiating factors. Ciba Found Symp. 1973;12:96–118.
32. Garin G. Abe J. Mohan A. Lu W. Yan C. Newby AC. Rhaman A. Berk BC. Flow antagonizes TNF-alpha signaling in endothelial cells by inhibiting caspase-dependent PKC zeta processing. Circ Res. 2007;101:97–105. [PubMed]
33. Gimbrone MA., Jr. Topper JN. Nagel T. Anderson KR. Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000;902:230–239. discussion 239–240. [PubMed]
34. Girard PR. Nerem RM. Shear stress modulates endothelial cell morphology and F-actin organization through the regulation of focal adhesion-associated proteins. J Cell Physiol. 1995;163:179–193. [PubMed]
35. Gotoh Y. Cooper JA. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J Biol Chem. 1998;273:17477–17482. [PubMed]
36. Haendeler J. Tischler V. Hoffmann J. Zeiher AM. Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett. 2004;577:427–433. [PubMed]
37. Helmlinger G. Geiger RV. Schreck S. Nerem RM. Effects of pulsatile flow on cultured vascular endothelial cell morphology. J Biomech Eng. 1991;113:123–131. [PubMed]
38. Henry PD. Chen CH. Inflammatory mechanisms of atheroma formation. Influence of fluid mechanics and lipid-derived inflammatory mediators. Am J Hypertens. 1993;6:328S–334S. [PubMed]
39. Hsiai TK. Cho SK. Wong PK. Ing M. Salazar A. Sevanian A. Navab M. Demer LL. Ho CM. Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J. 2003;17:1648–1657. [PubMed]
40. Hsiai TK. Hwang J. Barr ML. Correa A. Hamilton R. Alavi M. Rouhanizadeh M. Cadenas E. Hazen SL. Hemodynamics influences vascular peroxynitrite formation: implication for low-density lipoprotein apo-B-100 nitration. Free Radic Biol Med. 2007;42:519–529. [PMC free article] [PubMed]
41. Hwang J. Ing MH. Salazar A. Lassegue B. Griendling K. Navab M. Sevanian A. Hsiai TK. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res. 2003;93:1225–1232. [PubMed]
42. Hwang J. Saha A. Boo YC. Sorescu GP. McNally JS. Holland SM. Dikalov S. Giddens DP. Griendling KK. Harrison DG. Jo H. Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem. 2003;278:47291–47298. [PubMed]
43. Inoue N. Ramasamy S. Fukai T. Nerem RM. Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res. 1996;79:32–37. [PubMed]
44. Javaid K. Rahman A. Anwar KN. Frey RS. Minshall RD. Malik AB. Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1. Circ Res. 2003;92:1089–1097. [PubMed]
45. Kemphues K. PARsing embryonic polarity. Cell. 2000;101:345–348. [PubMed]
46. Knoblich JA. Epithelial polarity: the ins and outs of the fly epidermis. Curr Biol. 2000;10:R791–R794. [PubMed]
47. Ku DN. Giddens DP. Pulsatile flow in a model carotid bifurcation. Arteriosclerosis. 1983;3:31–39. [PubMed]
48. Ku DN. Giddens DP. Zarins CK. Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 1985;5:293–302. [PubMed]
49. Laurindo FR. Pedro Mde A. Barbeiro HV. Pileggi F. Carvalho MH. Augusto O. da Luz PL. Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res. 1994;74:700–709. [PubMed]
50. Levesque MJ. Liepsch D. Moravec S. Nerem RM. Correlation of endothelial cell shape and wall shear stress in a stenosed dog aorta. Arteriosclerosis. 1986;6:220–229. [PubMed]
51. Li JM. Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1014–R1030. [PubMed]
52. Lin K. Hsu PP. Chen BP. Yuan S. Usami S. Shyy JY. Li YS. Chien S. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A. 2000;97:9385–9389. [PubMed]
53. Liu H. Nishitoh H. Ichijo H. Kyriakis JM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol. 2000;20:2198–2208. [PMC free article] [PubMed]
54. Liu Y. Yin G. Surapisitchat J. Berk BC. Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest. 2001;107:917–923. [PMC free article] [PubMed]
55. Magid R. Davies PF. Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an athero-susceptible region of porcine aorta. Circ Res. 2005;97:443–449. [PMC free article] [PubMed]
56. Malek AM. Alper SL. Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282:2035–2042. [PubMed]
57. Matthews BD. Overby DR. Mannix R. Ingber DE. Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci. 2006;119:508–518. [PubMed]
58. McCue S. Dajnowiec D. Xu F. Zhang M. Jackson MR. Langille BL. Shear stress regulates forward and reverse planar cell polarity of vascular endothelium in vivo and in vitro. Circ Res. 2006;98:939–946. [PubMed]
59. McNally JS. Davis ME. Giddens DP. Saha A. Hwang J. Dikalov S. Jo H. Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol. 2003;285:H2290–H2297. [PubMed]
60. McNally JS. Saxena A. Cai H. Dikalov S. Harrison DG. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol. 2005;25:1623–1628. [PubMed]
61. Mowbray AL. Kang DH. Rhee SG. Kang SW. Jo H. Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant. J Biol Chem. 2008;283:1622–1627. [PubMed]
62. Nagel T. Resnick N. Dewey CF., Jr. Gimbrone MA., Jr. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol. 1999;19:1825–1834. [PubMed]
63. Nerem RM. Alexander RW. Chappell DC. Medford RM. Varner SE. Taylor WR. The study of the influence of flow on vascular endothelial biology. Am J Med Sci. 1998;316:169–175. [PubMed]
64. Ni CW. Qiu H. Rezvan A. Kwon K. Nam D. Son DJ. Visvader JE. Jo H. Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow. Blood. 2010;116:e66–e73. [PubMed]
65. Nigro P. Abe JI. Woo CH. Satoh K. McClain C. O'Dell MR. Lee H. Lim JH. Li JD. Heo KS. Fujiwara K. Berk BC. PKC{zeta} decreases eNOS protein stability via inhibitory phosphorylation of ERK5. Blood. 2010;116:1971–1979. [PubMed]
66. Noria S. Cowan DB. Gotlieb AI. Langille BL. Transient and steady-state effects of shear stress on endothelial cell adherens junctions. Circ Res. 1999;85:504–514. [PubMed]
67. Noria S. Xu F. McCue S. Jones M. Gotlieb AI. Langille BL. Assembly and reorientation of stress fibers drives morphological changes to endothelial cells exposed to shear stress. Am J Pathol. 2004;164:1211–1223. [PubMed]
68. Pan S. World C. Kovacs C. Berk B. Glucose 6-phosphate dehydrogenase is regulated through c-Src mediated tyrosine phosphorylation in endothelial cells. ATVB. 2009;29:895–901. [PubMed]
69. Parmar KM. Larman HB. Dai G. Zhang Y. Wang ET. Moorthy SN. Kratz JR. Lin Z. Jain MK. Gimbrone MA., Jr. Garcia-Cardena G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49–58. [PMC free article] [PubMed]
70. Passerini AG. Polacek DC. Shi C. Francesco NM. Manduchi E. Grant GR. Pritchard WF. Powell S. Chang GY. Stoeckert CJ., Jr. Davies PF. Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci U S A. 2004;101:2482–2487. [PubMed]
71. Pi X. Yan C. Berk BC. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res. 2004;94:362–369. [PubMed]
72. Rahman A. Bando M. Kefer J. Anwar KN. Malik AB. Protein kinase C-activated oxidant generation in endothelial cells signals intercellular adhesion molecule-1 gene transcription. Mol Pharmacol. 1999;55:575–583. [PubMed]
73. Regan CP. Li W. Boucher DM. Spatz S. Su MS. Kuida K. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci U S A. 2002;99:9248–9253. [PubMed]
74. Resnick N. Yahav H. Shay-Salit A. Shushy M. Schubert S. Zilberman LC. Wofovitz E. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003;81:177–199. [PubMed]
75. Rezvan A. Ni CW. Alberts-Grill N. Jo H. Animal, in vitro, and ex vivo models of flow-dependent atherosclerosis: role of oxidative stress. Antioxid Redox Signal. 2011;15:1433–1448. [PMC free article] [PubMed]
76. Rogers KA. Kalnins VI. Comparison of the cytoskeleton in aortic endothelial cells in situ and in vitro. Lab Invest. 1983;49:650–654. [PubMed]
77. Rogers KA. McKee NH. Kalnins VI. Preferential orientation of centrioles toward the heart in endothelial cells of major blood vessels is reestablished after reversal of a segment. Proc Natl Acad Sci U S A. 1985;82:3272–3276. [PubMed]
78. Rokitansky C. London: Sydenham Soc; 1952. A Manual of Pathological Anatomy, Vol. 4; pp. 1849–1854.
79. Saitoh M. Nishitoh H. Fujii M. Takeda K. Tobiume K. Sawada Y. Kawabata M. Miyazono K. Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17:2596–2606. [PubMed]
80. Shulman JM. St. Johnston D. Pattern formation in single cells. Trends Cell Biol. 1999;9:M60–M64. [PubMed]
81. Silacci P. Desgeorges A. Mazzolai L. Chambaz C. Hayoz D. Flow pulsatility is a critical determinant of oxidative stress in endothelial cells. Hypertension. 2001;38:1162–1166. [PubMed]
82. Smith L. Chen L. Reyland ME. DeVries TA. Talanian RV. Omura S. Smith JB. Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J Biol Chem. 2000;275:40620–40627. [PubMed]
83. Smith L. Wang Z. Smith JB. Caspase processing activates atypical protein kinase C zeta by relieving autoinhibition and destabilizes the protein. Biochem J. 2003;375:663–671. [PubMed]
84. Sorescu GP. Song H. Tressel SL. Hwang J. Dikalov S. Smith DA. Boyd NL. Platt MO. Lassegue B. Griendling KK. Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res. 2004;95:773–779. [PubMed]
85. Stocker R. Keaney JF., Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–1478. [PubMed]
86. Surapisitchat J. Hoefen RJ. Pi X. Yoshizumi M. Yan C. Berk BC. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proc Natl Acad Sci U S A. 2001;98:6476–6481. [PubMed]
87. Takeshita S. Inoue N. Ueyama T. Kawashima S. Yokoyama M. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun. 2000;273:66–71. [PubMed]
88. Topper JN. Cai J. Falb D. Gimbrone MA., Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996;93:10417–10422. [PubMed]
89. Tzima E. Kiosses WB. del Pozo MA. Schwartz MA. Localized cdc42 activation, detected using a novel assay, mediates microtubule organizing center positioning in endothelial cells in response to fluid shear stress. J Biol Chem. 2003;278:31020–31023. [PubMed]
90. Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI—Atheromatous affection of arteries. 1858. Nutr Rev. 1989;47:23–25. [PubMed]
91. Wasserman SM. Mehraban F. Komuves LG. Yang RB. Tomlinson JE. Zhang Y. Spriggs F. Topper JN. Gene expression profile of human endothelial cells exposed to sustained fluid shear stress. Physiol Genomics. 2002;12:13–23. [PubMed]
92. Wasserman SM. Topper JN. Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications. Vasc Med. 2004;9:35–45. [PubMed]
93. Wootton DM. Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng. 1999;1:299–329. [PubMed]
94. Yamashita T. Yamamoto E. Kataoka K. Nakamura T. Matsuba S. Tokutomi Y. Dong YF. Ichijo H. Ogawa H. Kim-Mitsuyama S. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency. Hypertension. 2007;50:519–524. [PubMed]
95. Yamawaki H. Berk BC. Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens. 2005;14:149–153. [PubMed]
96. Yamawaki H. Lehoux S. Berk BC. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation. 2003;108:1619–1625. [PubMed]
97. Yun S. Dardik A. Haga M. Yamashita A. Yamaguchi S. Koh Y. Madri JA. Sumpio BE. Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium. J Biol Chem. 2002;277:34808–34814. [PubMed]
98. Zarins CK. Giddens DP. Bharadvaj BK. Sottiurai VS. Mabon RF. Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res. 1983;53:502–514. [PubMed]
99. Ziegler T. Bouzourene K. Harrison VJ. Brunner HR. Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18:686–692. [PubMed]

Articles from Antioxidants & Redox Signaling are provided here courtesy of Mary Ann Liebert, Inc.